Howard L Corwin

Summary

Affiliation: Dartmouth-Hitchcock Medical Center
Country: USA

Publications

  1. ncbi Roundtable debate: Controversies in the management of the septic patient--desperately seeking consensus
    Aaron B Waxman
    Pulmonary Critical Care Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Crit Care 9:E1. 2005
  2. ncbi Erythropoietin in the critically ill - is it more than just blood?
    Howard L Corwin
    Dartmouth Medical School, Lebanon, New Hampshire, USA
    Crit Care 8:325-6. 2004
  3. ncbi Anemia and blood transfusion in the critically ill patient: role of erythropoietin
    Howard L Corwin
    Dartmouth Medical School, Critical Care Medicine, Intensive Care Unit, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA
    Crit Care 8:S42-4. 2004
  4. ncbi Blood conservation in the critically ill patient
    Howard L Corwin
    Dartmouth Medical School, HB 7999, Hanover, NH 03755, and Critical Care Medicine, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, USA
    Anesthesiol Clin North America 23:363-72, viii. 2005
  5. ncbi Transfusion practice in the critically ill
    Howard L Corwin
    Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA
    Crit Care Med 31:S668-71. 2003
  6. ncbi The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States
    Howard L Corwin
    Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA
    Crit Care Med 32:39-52. 2004
  7. ncbi Anemia and red blood cell transfusion in the critically ill
    Howard L Corwin
    Section of Critical Care Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA
    Semin Dial 19:513-6. 2006
  8. ncbi Efficacy and safety of epoetin alfa in critically ill patients
    Howard L Corwin
    Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA
    N Engl J Med 357:965-76. 2007
  9. ncbi Erythropoietin use in critically ill patients: forest and trees
    Howard L Corwin
    Department of Critical Care Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA
    CMAJ 177:747-9. 2007
  10. ncbi Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial
    Howard L Corwin
    Critical Care Medicine, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, USA
    JAMA 288:2827-35. 2002

Collaborators

Detail Information

Publications31

  1. ncbi Roundtable debate: Controversies in the management of the septic patient--desperately seeking consensus
    Aaron B Waxman
    Pulmonary Critical Care Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Crit Care 9:E1. 2005
    ..This presentation is intended to show how experienced intensivists apply clinical science to their practice of critical care medicine...
  2. ncbi Erythropoietin in the critically ill - is it more than just blood?
    Howard L Corwin
    Dartmouth Medical School, Lebanon, New Hampshire, USA
    Crit Care 8:325-6. 2004
    ..Recently it has been demonstrated that EPO has actions other than stimulating the bone marrow. It has been suggested that due to its tissue protecting effect, EPO may be effective in improving outcome in the critically ill...
  3. ncbi Anemia and blood transfusion in the critically ill patient: role of erythropoietin
    Howard L Corwin
    Dartmouth Medical School, Critical Care Medicine, Intensive Care Unit, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA
    Crit Care 8:S42-4. 2004
    ..Strategies to increase the production of RBCs are complementary to other approaches to reduce blood loss in the intensive care unit, and they decrease the transfusion threshold in the management of all critically ill patients...
  4. ncbi Blood conservation in the critically ill patient
    Howard L Corwin
    Dartmouth Medical School, HB 7999, Hanover, NH 03755, and Critical Care Medicine, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, USA
    Anesthesiol Clin North America 23:363-72, viii. 2005
    ..This review focuses on transfusion practice in the critically ill...
  5. ncbi Transfusion practice in the critically ill
    Howard L Corwin
    Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA
    Crit Care Med 31:S668-71. 2003
    ..This anemia of critical illness is a distinct clinical entity characterized by blunted erythropoietin production and abnormalities in iron metabolism identical to what is commonly referred to as the anemia of chronic disease...
  6. ncbi The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States
    Howard L Corwin
    Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA
    Crit Care Med 32:39-52. 2004
    ..To quantify the incidence of anemia and red blood cell (RBC) transfusion practice in critically ill patients and to examine the relationship of anemia and RBC transfusion to clinical outcomes...
  7. ncbi Anemia and red blood cell transfusion in the critically ill
    Howard L Corwin
    Section of Critical Care Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA
    Semin Dial 19:513-6. 2006
    ..Strategies to minimize loss of blood and increase the production of RBCs are also important in the management of all critically ill patients...
  8. ncbi Efficacy and safety of epoetin alfa in critically ill patients
    Howard L Corwin
    Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA
    N Engl J Med 357:965-76. 2007
    ..We hypothesized that therapy with recombinant human erythropoietin (epoetin alfa) might reduce the need for red-cell transfusions...
  9. ncbi Erythropoietin use in critically ill patients: forest and trees
    Howard L Corwin
    Department of Critical Care Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA
    CMAJ 177:747-9. 2007
  10. ncbi Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial
    Howard L Corwin
    Critical Care Medicine, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, USA
    JAMA 288:2827-35. 2002
    ..Anemia is common in critically ill patients and results in a large number of red blood cell (RBC) transfusions. Recent data have raised the concern that RBC transfusions may be associated with worse clinical outcomes in some patients...
  11. ncbi Multiple reservoirs contribute to intraoperative bacterial transmission
    Randy W Loftus
    Department of Anesthesiology, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA
    Anesth Analg 114:1236-48. 2012
    ..Pulsed-field gel electrophoresis was used to assess the contribution of reservoir bacterial pathogens to 30-day postoperative infections...
  12. ncbi The role of erythropoietin therapy in the critically ill
    Howard L Corwin
    Dartmouth Medical School, Lebanon, NH 03756, USA
    Transfus Med Rev 20:27-33. 2006
    ..Strategies to increase the production of RBCs are complementary to other approaches to reduce blood loss in the ICU and decrease the transfusion threshold in the management of all critically ill patients...
  13. ncbi Reduction in ventilator associated pneumonia in a mixed intensive care unit after initiation of a novel hand hygiene program
    Matthew D Koff
    Department of Anesthesiology, Section of Critical Care Medicine, Dartmouth Hitchcock Medical Center, 1 Medical Center Dr, Lebanon, NH 03756
    J Crit Care 26:489-95. 2011
    ..Infect Control Hosp Epidemiol 19:858-860, 1998). Contamination of provider hands may be a modifiable risk factor. We instituted a novel multimodal system designed to improve hand hygiene by ICU providers...
  14. ncbi New developments in massive transfusion in trauma
    Sarah E Greer
    Dartmouth Hitchcock Medical Center, Departments of Surgery, USA
    Curr Opin Anaesthesiol 23:246-50. 2010
    ..This review describes recent advances in the early recognition and treatment of the coagulopathy of trauma, as well as ongoing work to define optimal resuscitation strategies...
  15. ncbi Hand contamination of anesthesia providers is an important risk factor for intraoperative bacterial transmission
    Randy W Loftus
    Department of Anesthesiology and Critical Care Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA
    Anesth Analg 112:98-105. 2011
    ..In this study, we hypothesized that bacterial contamination of anesthesia provider hands before patient contact is a risk factor for direct intraoperative bacterial transmission...
  16. ncbi Improved survival of critically ill trauma patients treated with recombinant human erythropoietin
    Lena M Napolitano
    Department of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0033, USA
    J Trauma 65:285-97; discussion 297-9. 2008
    ..7% vs. 3.5%). This analysis presents trauma cohort data from both trials for evaluation of the impact of baseline factors including trauma-specific variables on outcomes...
  17. ncbi Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature
    Paul E Marik
    Division of Pulmonary and Critical Care Medicine, Thomas Jefferson University, Philadelphia, PA, USA
    Crit Care Med 36:2667-74. 2008
    ..However, the hematocrit that should be maintained in any particular patient because the risks of further transfusion of RBC outweigh the benefits remains unclear...
  18. ncbi Transfusion practice in the critically ill: can we do better?
    Howard L Corwin
    Crit Care Med 33:232-3. 2005
  19. ncbi Controversies in RBC transfusion in the critically ill
    Paul C Hebert
    Centre for Transfusion Research, University of Ottawa, and Clinical Epidemiology Program of the Ottawa Health Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada
    Chest 131:1583-90. 2007
    ..This review will examine some of the important controversies still surrounding the use of RBC transfusion in the critically ill patient...
  20. ncbi Blood transfusion--when is more really less?
    Howard L Corwin
    N Engl J Med 356:1667-9. 2007
  21. ncbi Avoiding a blood transfusion: How much is it worth?
    Howard L Corwin
    Crit Care Med 33:672-4. 2005
  22. ncbi Anemia and blood transfusion in trauma patients admitted to the intensive care unit
    Marc J Shapiro
    Department of Surgery, Saint Louis University, Missouri 63110 0250, USA
    J Trauma 55:269-73; discussion 273-4. 2003
    ..The issue of blood use in critically injured patients requires evaluation...
  23. ncbi Erythropoietin in the critically ill: what is the evidence?
    Howard L Corwin
    Nephrol Dial Transplant 20:2605-8. 2005
  24. ncbi Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial
    Michael Silver
    Kindred Health Care, Chicago, IL, USA
    Crit Care Med 34:2310-6. 2006
    ..Despite receiving fewer red blood cell transfusions, patients treated with rHuEPO achieve a higher hemoglobin level...
  25. ncbi Efficacy of red blood cell transfusion in the critically ill
    Lena M Napolitano
    Department of Surgery, University of Maryland School of Medicine, 22 South Greene Street, Baltimore, MD 21201, USA
    Crit Care Clin 20:255-68. 2004
    ....
  26. ncbi Acute lung injury following blood transfusion: expanding the definition
    Paul E Marik
    Division of Pulmonary and Critical Care Medicine, Thomas Jefferson University, Philadelphia, PA, USA
    Crit Care Med 36:3080-4. 2008
    ..The objectives of this review are to summarize current knowledge of TRALI with an emphasis on issues pertinent to the intensivist and to define the newly recognized "Delayed TRALI syndrome."..
  27. ncbi Efficacy of blood transfusion in the critically ill: does age of blood make a difference?
    Lena M Napolitano
    Crit Care Med 32:594-5. 2004
  28. ncbi Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial
    Neil Singla
    Department of Anesthesia, Huntington Memorial Hospital, Pasadena, California 91105, USA
    Anesth Analg 107:59-67. 2008
    ..In this double-blind, placebo-controlled trial, we examined the efficacy and safety of clevidipine in treating postoperative hypertension in cardiac surgery patients...
  29. ncbi Transfusion in critical care: where do we go from here?
    Andrew F Shorr
    Chest 132:1105-6. 2007
  30. ncbi Is leukoreduction of blood components for everyone?
    Howard L Corwin
    JAMA 289:1993-5. 2003
  31. ncbi Teamwork and collaboration in critical care: lessons from the cockpit
    Stephen D Surgenor
    Crit Care Med 31:992-3. 2003